$476 Million is the total value of AIGH Capital Management LLC's 101 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EMKR | EMCORE CORP | $25,209,000 | -18.9% | 3,370,153 | 0.0% | 5.30% | -5.2% | |
| AVNW | AVIAT NETWORKS INC | $18,227,000 | +0.3% | 554,682 | 0.0% | 3.83% | +17.1% | |
| EDAP | EDAP TMS S Asponsored adr | $7,709,000 | -10.0% | 1,208,250 | 0.0% | 1.62% | +5.1% | |
| AVYA | AVAYA HLDGS CORPcall | $5,937,000 | -26.4% | 300,000 | 0.0% | 1.25% | -14.0% | |
| FKWL | FRANKLIN WIRELESS CORP | $5,663,000 | -23.5% | 780,000 | 0.0% | 1.19% | -10.7% | |
| RFIL | RF INDS LTD | $4,035,000 | +9.2% | 495,037 | 0.0% | 0.85% | +27.7% | |
| BKTI | BK TECHNOLOGIES CORPORATION | $3,786,000 | -10.3% | 1,340,000 | 0.0% | 0.80% | +4.7% | |
| ALNA | ALLENA PHARMACEUTICALS | $3,608,000 | -30.6% | 4,000,000 | 0.0% | 0.76% | -18.9% | |
| HTGM | HTG MOLECULAR DIAGNOSTICS IN | $3,494,000 | -1.7% | 612,000 | 0.0% | 0.74% | +14.8% | |
| PCSA | PROCESSA PHARMACEUTICALS INC | $3,317,000 | +4.6% | 387,097 | 0.0% | 0.70% | +22.2% | |
| DAIO | DATA I O CORP | $2,731,000 | -4.1% | 418,310 | 0.0% | 0.57% | +11.9% | |
| MDNA | MEDICENNA THERAPEUTICS CORP | $2,544,000 | -8.1% | 915,000 | 0.0% | 0.54% | +7.4% | |
| EVOK | EVOKE PHARMA INC | $2,211,000 | -5.1% | 1,701,185 | 0.0% | 0.46% | +10.7% | |
| IDEAL PWR INC | $2,197,000 | +19.7% | 144,347 | 0.0% | 0.46% | +40.0% | ||
| ALIMERA SCIENCES INC | $2,115,000 | -53.6% | 501,025 | 0.0% | 0.44% | -45.8% | ||
| NLSPW | NLS PHARMACEUTICS LTDcall | $2,069,000 | +137.3% | 827,921 | 0.0% | 0.44% | +177.1% | |
| YTEN | YIELD10 BIOSCIENCE INC | $2,049,000 | -29.8% | 342,000 | 0.0% | 0.43% | -17.9% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AVIAT NETWORKS INC | 12 | Q3 2023 | 6.8% |
| SCPHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| THERATECHNOLOGIES INC | 11 | Q2 2023 | 2.9% |
| FRANKLIN WIRELESS CORP | 11 | Q3 2023 | 2.9% |
| IDEAL PWR INC | 11 | Q3 2023 | 2.5% |
| MEDICENNA THERAPEUTICS CORP | 11 | Q3 2023 | 1.1% |
| PARATEK PHARMACEUTICALS INC | 10 | Q1 2023 | 3.2% |
| LIGHTPATH TECHNOLOGIES INC | 10 | Q3 2023 | 3.0% |
| MYOMO INC | 10 | Q3 2023 | 1.3% |
| DZS INC | 9 | Q1 2023 | 7.5% |
View AIGH Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Bridgeline Digital, Inc. | May 21, 2021 | 627,419 | 9.7% |
View AIGH Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-12 |
View AIGH Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.